Glucocorticoid-related osteoporotic fractures

Singapore Medical Journal

Volumn 51, Issue 12, 2010, Pages 948-951

  Al Osail, A M ^a   Sadat Ali, Mir ^b   Al Elq, A H ^a   Al Omran, A S ^b   Azzam, Q ^b  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b Department of Orthopaedic Surgery ^*

Author keywords

Glucocorticoids; Osteoporosis related fractures; Secondary osteoporosis

Indexed keywords

GLUCOCORTICOID;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG USE; FEMALE; FEMUR FRACTURE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SPINE FRACTURE; TREATMENT DURATION; VERTEBRA FRACTURE;

ADULT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; FEMALE; FEMORAL FRACTURES; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; MALE; OSTEOPOROSIS; PREDNISONE; SEX FACTORS; SPINAL FRACTURES;

EID: 79951837287     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ardawi MS, Maimany AA, Bahksh TM, et al. Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int 2005; 16:43-55.
2. Sadat-Ali M, Al-Habdan I, Al-Mulhim Fatma, El-Hassan AY. Bone Mineral density among postmenopausal Saudi Arabian women. Saudi Med J 2004; 25:1623-5.
3. Sadat-Ali M, Al-Elq A. Osteoporosis among male Saudi Arabs. A pilot study. Ann Saudi Med 2006; 26:450-4.
4. El-Desouki M. Sulaimani R. High prevalence of osteoporosis in Saudi men. Saudi Med J 2007; 28:774-7.
5. Laan RF, Buijs WC, van Erning LJ, et al. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 1993; 52:5-9.
6. American college of Rheumatology Ad Hoc Committee on glucocorticod-induced osteoporosis. Recommendation for the prevention and treatment of glucocorticod-induced osteoporosis. 2001 Update. Arthritis and Rheumat 2001; 44:1496-503.
7. Adler RA, Hochberg MC. Suggested guidelines for evaluation and treatment of glucocorticod-induced osteoporosis for the Department of Veterans Affairs. Arch Intern Med. 2003; 163:2619-24.
8. National Osteoporosis Society. Guidelines on the prevention and management of corticosteroid-induced osteoporosis. Bath, England: National Osteoporosis Society; 1998.
9. Eastell R, Reid DM, Compston J et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998; 244:271-92.
10. Sadat-Ali M, Alelq AH, Alshafei BA, Al-Turki HA, Abujubara MA. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Ann Saudi Med 2009; 29:215-8.
11. Walsh IJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996; 313:344-6.
12. Gudbjornsson B, Juliusson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann rheum Dis 2002; 61:32-6.
13. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002; 13:777-87.
14. Genant HK, Wu CY, Van Kuijk C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8:1137-48.
15. Sosa M, Jodar E, Saavedra P, et al. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone. Eur J Intern Med 2008; 19:51-6.
16. Naganathan V, Jones G, Nash P, et al. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med. 2000; 160:2917-22.
17. Luengo M, Picado C, Del Rio L, et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991; 46:803-6.
18. van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000; 39:1383-9.
19. Steinbuch M, Youket TE, Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 2004; 15:323-8.
20. de Vries F, Bracke M, Leufkens HGM, Lammers J-W J, Cooper C, van Staa TP. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 2007; 56:208-14.
21. Angeli A, Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 2006; 39:253-9.